investingreview.org logo
Avoid Fraud, Get The Facts, And Find The Best
Nothings Found.

CX Institutional Q2 2023 vs. Q3 2023: Major Shifts in Fund Holdings

Ava Hoppe | 19 October, 2023

Institutional investors play a crucial role in the financial market, and their portfolio changes often attract attention. This article examines the significant shifts in holdings of CX Institutional's portfolio between Q2 2023 and Q3 2023. The data reveals interesting trends and potential insights into the investment strategy of CX Institutional.

iShares Core S&P 500 (IVV): A Reduction in Shares

CX Institutional decreased its holdings in the iShares Core S&P 500 (IVV) by 18.8% between Q2 2023 and Q3 2023. This reduction amounts to 22,722 shares, with a corresponding decrease in value by $11,794,000. While the exact reasoning behind this decision is unknown, it suggests a possible change in market sentiment towards this particular ETF.

SPDR Portfolio Intmdt Term Trs ETF (SPTI): Decreased Exposure

Another significant change in CX Institutional's holdings is the reduction of holdings in the SPDR Portfolio Intmdt Term Trs ETF (SPTI). The number of shares decreased by 16.9%, translating to a total of 266,203 shares. The value of the holdings declined by $8,641,000, indicating a change in the fund's exposure to intermediate-term Treasury bonds.

Vanguard Short-Term Bond Index ETF (BSV): A Surprising Increase

In contrast to the previous examples, CX Institutional's holdings in the Vanguard Short-Term Bond Index ETF (BSV) experienced a significant increase during Q2 2023 and Q3 2023. The number of shares jumped by a remarkable 90.7%, amounting to an additional 209,968 shares. This surge in holdings emphasizes the fund's interest in short-term bonds as a potential safe haven or income-generating source.

iShares S&P 500 Value ETF (IVE): A Strong Showing

CX Institutional showed a notable interest in the iShares S&P 500 Value ETF (IVE) during this period. The number of shares held increased by 49.5%, equivalent to a rise of 74,341 shares. This move aligns with the current trend of investors pivoting towards value-focused stocks and reinforces the fund's confidence in this particular ETF.

iShares Barclays 20 Yr Treasury Bond (TLT): A Substantial Increase

CX Institutional significantly increased its holdings in the iShares Barclays 20 Yr Treasury Bond (TLT). The number of shares surged by an impressive 84.9%, resulting in an additional 188,567 shares. This move could indicate a shift towards long-term government bonds, potentially as a hedge against market volatility.

SPDR Portfolio Corporate Bond ETF (SPBO): Steady Growth

The holdings of the SPDR Portfolio Corporate Bond ETF (SPBO) experienced modest growth during Q2 2023 and Q3 2023. CX Institutional increased its position in this ETF by 9.4%, representing an additional 139,426 shares. With corporate bonds offering attractive yields in times of low-interest rates, this move reflects the fund's confidence in this segment of the fixed-income market.

These are just a few examples of the significant shifts in CX Institutional's holdings during Q2 2023 and Q3 2023. While it is important to note that these changes represent only a fraction of their total portfolio, they provide valuable insights into the fund's investment strategy and potential market dynamics. As always, it is crucial for investors to conduct thorough research and seek professional advice when making investment decisions based on these trends.

Many people have been burned by frauds and Ponzi schemes. So we created this website to help you, the potential investor, get the facts, find the best, and avoid fraud and Ponzi schemes.

All information provided on this website is provided without warranty and for informational purposes only.
InvestingReview.org does not provide investment advice. InvestingReview.org is not an investment adviser and is not endorsed by or affiliated with any U.S. or non-U.S. regulatory agency.


Recently Searched Firms

Please note: Search data is accumulated by 3rd party and refreshed once per day.

Copyright © 2023 by InvestingReview.org / All Rights Reserved.